Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: A pooled analysis of 1,322 patients with hepatitis C infection

por Reau, Nancy, Robertson, Michael N., Feng, Hwa‐Ping, Caro, Luzelena, Yeh, Wendy W., Nguyen, Bach‐Yen T., Wahl, Janice, Barr, Eliav, Hwang, Peggy, Klopfer, Stephanie O.
Publicado 2017

The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study

por Kumada, Hiromitsu, Suzuki, Yoshiyuki, Karino, Yoshiyasu, Chayama, Kazuaki, Kawada, Norifumi, Okanoue, Takeshi, Itoh, Yoshito, Mochida, Satoshi, Toyoda, Hidenori, Yoshiji, Hitoshi, Takaki, Shintaro, Yatsuzuka, Naoyoshi, Yodoya, Etsuo, Iwasa, Takashi, Fujimoto, Go, Robertson, Michael N., Black, Stuart, Caro, Luzelena, Wahl, Janice
Publicado 2016

Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection

por George, Jacob, Burnevich, Eduard, Sheen, I‐Shyan, Heo, Jeong, Kinh, Nguyen Van, Tanwandee, Tawesak, Cheng, Pin‐Nan, Kim, Do Young, Tak, Won Young, Kizhlo, Svetlana, Zhdanov, Konstantin, Isakov, Vasily, Liang, Liwen, Lindore, Pauline, Ginanni, Joy, Nguyen, Bach‐Yen, Wahl, Janice, Barr, Eliav, Robertson, Michael, Ingravallo, Paul, Talwani, Rohit
Publicado 2018